Sortase-catalyzed immobilization, release, and replacement of functional molecules on solid surfaces

Patent metadata

Field	Value
Publication number	US-2015284477-A1
Application number	US-201314439787-A
Country	US
Kind code	A1
Filing date	Oct 30, 2013
Priority date	Oct 30, 2012
Publication date	Oct 8, 2015
Grant date	—

Abstract

Compositions, reagents, kits, and methods for the reversible, covalent conjugation of functional molecules to engineered surfaces, e.g., surfaces of biomedical devices or used in analytical assays or industrial catalysis, are provided. The compositions, reagents, kits, and methods provided herein allow for the attachment, release, and replacement of functional molecules to and from engineered surfaces in vitro, in situ, and in vivo. Implantable vascular grafts, stents, catheters, and other medical devices with immobilized thrombomodulin-coated surfaces are provided. These molecules can be released from the device surface and replaced with fresh thrombomodulin via systemic administration of the respective reactants and without the need to remove the device.

First claim

1 . A composition comprising,
an engineered solid support, and a first sortase recognition motif conjugated to the surface of the solid support.

2 . The composition of claim 1 , wherein the solid support comprises a polymer or copolymer.

3 . (canceled)

4 . The composition of claim 2 , wherein the polymer or co-polymer is chosen from the group consisting of polyurethane polymers and copolymers thereof, polyoxymethylene polymers and copolymers thereof, polyamide polymers and copolymers thereof, polyacrylamide polymers and copolymers thereof, polyvinyl polymers and copolymers thereof, styrene-ethylene-butylene copolymers, styrene-isoprene copolymers, polyether polymers and copolymers thereof, polyolefin polymers and copolymers thereof, polypropylene polymers and copolymers thereof, polyethylene polymers and copolymers thereof, polytetrafluoroethylene (PTFE) polymers and copolymers thereof, polyoxypropylene polymers and copolymers thereof, polyoxyethylene polymers and copolymers thereof, polyanhydride polymers and copolymers thereof, polyvinylalcohol polymers and copolymers thereof, and polyethyleneamine polymers and copolymers thereof.

5 . The composition of claim 1 , wherein the first sortase recognition motif comprises a polyglycine sequence.

6 - 7 . (canceled)

8 . The composition of claim 1 , wherein the first sortase recognition motif comprises an LPXT motif, wherein X represents any amino acid.

9 . The composition of claim 8 , wherein the first sortase recognition motif comprises an LPETG (SEQ ID NO: 4) motif.

10 . The composition of claim 1 , wherein the solid support can be conjugated to a functional molecule conjugated to a second sortase recognition motif via a sortase-mediated transpeptidation, wherein the second sortase recognition motif can be used by a sortase as a substrate of a transpeptidation reaction involving the first sortase recognition motif.

11 . The composition of claim 1 , wherein the solid support is conjugated to a functional molecule comprising a second sortase recognition motif.

12 . The composition of claim 10 , wherein the composition comprises a [solid support]-[polyglycine sequence]-[LPXT]-[functional molecule] structure, or a [solid support]-[LPXT]-[polyglycine sequence]-[functional molecule] structure.

13 . The composition of claim 1 , wherein the solid support is in contact with a body fluid or tissue of a subject.

14 . (canceled)

15 . The composition of claim 11 , wherein the functional molecule has anti-coagulant activity.

16 . The composition of claim 15 , wherein the functional molecule is thrombomodulin.

17 . The composition of claim 1 , wherein the composition is an implantable medical device.

18 - 20 . (canceled)

21 . The composition of claim 1 , wherein the composition is in contact with a cell or cell population.

22 - 23 . (canceled)

24 . The composition of claim 11 , wherein the functional molecule is a cell adhesion molecule.

25 . The composition of claim 11 , wherein the functional molecule is laminin or fibronectin.

26 . The composition of claim 1 , wherein the composition is in contact with an analyte in a sample.

27 - 31 . (canceled)

32 . The composition of claim 11 , wherein the functional molecule is a binding molecule that specifically binds the analyte.

33 . The composition of claim 32 , wherein the functional molecule comprises an antibody or an antibody fragment.

34 . (canceled)

35 . A method comprising
contacting the composition of claim 1 with a sortase under conditions for the sortase to catalyze a transpeptidation reaction.

36 . A composition comprising,
an engineered solid support, and a functional molecule conjugated to the surface of the solid support via sortase-mediated transpeptidation.

37 - 48 . (canceled)

49 . A method for functionalizing a solid support surface, the method comprising
contacting a first sortase recognition motif conjugated to a solid support with a functional molecule conjugated to a second sortase recognition motif in the presence of a sortase and under conditions suitable for the sortase to catalyze a transpeptidation reaction conjugating the functional molecule to the solid support.

50 - 72 . (canceled)

73 . A method comprising
contacting a first functional molecule conjugated to a solid support comprising a first and a second sortase recognition motif with a sortase in the presence of a peptide comprising the first sortase recognition motif under conditions suitable for the sortase to catalyze a transpeptidation reaction that releases the first functional molecule and the second sortase recognition motif from the solid support and that restores the first sortase recognition motif conjugated to the solid support.

74 - 119 . (canceled)

Assignees

• President and Fellows of Haverd College
• Beth Israel Hospital

Inventors

• Chaikof Elliot
• Qu Zheng
• Haller Carolyn
• Liu David R
• Dorr Brent M

Classifications

• C08G81/00

  Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers (involving only carbon-to-carbon unsaturated bond reactions C08F299/00 {; polyester-amides C08G69/44; polyester-imides C08G73/16; polyamides-imides C08G73/14; block- or graft polymers containing polysiloxane sequences C08G77/42}) · CPC title

• A61L2400/18

  Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment · CPC title

• A61L33/18

  Use of ingredients of undetermined constitution or reaction products thereof · CPC title

• C12Y304/2207

  Sortase A (3.4.22.70) · CPC title

• C12N9/52

  derived from bacteria {or Archaea} · CPC title